ipilimumab,INT230-6
bms,intensity therapeutics
[' ipi ', 'sarcoma', 'immunogen']
come see the poster involving giles whalen explaining how int-230-6 given intratumorally alone or with ipi causes #immunogenic #celldeath and excellent #tumor control. it also works in #sarcomas which are usually unresponsive to #immunotherapy. #asco2022 
Advancing #CancerResearch with hallmark in basic science | Affiliated with @UMassChan